Dietary fat level affects tissue iron levels but not the iron regulatory gene HAMP in rats

Nutrition Research

Volumn 33, Issue 2, 2013, Pages 126-135

  Ahmed, Umbreen ^a   Oates, Phillip S ^b  

^a NATIONAL UNIVERSITY OF SCIENCES AND TECHNOLOGY   (Pakistan)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

C EBP ; Dietary fat; Hemochromatosis protein; Hepcidin; IL 6; Iron; Iron dextran; Nonalcoholic fatty liver disease; Rat model; TNF

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; HEMOGLOBIN; HEMOJUVELIN; HEPCIDIN; HFE PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; MESSENGER RNA; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFERRIN RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEBP ALPHA GENE; CONTROLLED STUDY; DMT1 GENE; GENE; GENE EXPRESSION REGULATION; HAMP GENE; HEMOGLOBIN BLOOD LEVEL; HFE GENE; HJV GENE; IL 1 GENE; IL 6 GENE; IRON BALANCE; IRON BLOOD LEVEL; IRON METABOLISM; IRON RESPONSIVE ELEMENT; IRON TRANSPORT; LIPID COMPOSITION; LIPID DIET; LIPID METABOLISM; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MOLECULAR INTERACTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; NUTRITIONAL STATUS; PLASMA OSMOLALITY; PPAR GAMMA GENE; PRIORITY JOURNAL; RAT; REGULATOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TFR2 GENE; TISSUE LEVEL; TNF ALPHA GENE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CARRIER PROTEINS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; DIET; DIET, HIGH-FAT; DIETARY FATS; ENERGY INTAKE; FATTY LIVER; HEMOCHROMATOSIS; HEMOGLOBINS; INTERLEUKIN-6; IRON; IRON, DIETARY; LIVER; MALE; OSMOLAR CONCENTRATION; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SPLEEN; TRANSFERRIN; TUMOR NECROSIS FACTOR-ALPHA;

RATTUS;

EID: 84873522131     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.11.012     Document Type: Article

References (58)

1. Ahmed U., Latham P.S., Oates P.S. Interactions between hepatic iron and lipid metabolism with possible relevance to steatohepatitis. World J Gastroenterol 2012, 18:4651-4658.
2. Ahmed F., Coyne T., Dobson A., McClintock C. Iron status among Australian adults: findings of a population based study in Queensland, Australia. Asia Pac J Clin Nutr 2008, 17:40-47.
3. Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005, 11:183-190.
4. Roy C.N., Weinstein D.A., Andrews N.C. 2002 E. Mead Johnson Award for Research in Pediatrics Lecture: the molecular biology of the anemia of chronic disease: a hypothesis. Pediatr Res 2003, 53:507-512.
5. Graham R.M., Chua A.C., Herbison C.E., Olynyk J.K., Trinder D. Liver iron transport. World J Gastroenterol 2007, 13:4725-4736.
6. Oates P.S., Ahmed U. Molecular regulation of hepatic expression of iron regulatory hormone hepcidin. J Gastroenterol Hepatol 2007, 22:1378-1387.
7. Nemeth E., Valore E.V., Territo M., Schiller G., Lichtenstein A., Ganz T. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood 2003, 101:2461-2463.
8. Laftah A.H., Sharma N., Brookes M.J., McKie A.T., Simpson R.J., Iqbal T.H., et al. Tumour necrosis factor alpha causes hypoferraemia and reduced intestinal iron absorption in mice. Biochem J 2006, 397:61-67.
9. Lee P., Peng H., Gelbart T., Wang L., Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 2005, 102:1906-1910.
10. Dzikaite V., Holmstrom P., Stal P., Eckes K., Hagen K., Eggertsen G., et al. Regulatory effects of tumor necrosis factor-alpha and interleukin-6 on HAMP expression in iron loaded rat hepatocytes. J Hepatol 2006, 44:544-551.
11. Gavrilova O., Haluzik M., Matsusue K., Cutson J.J., Johnson L., Dietz K.R., et al. Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass. J Biol Chem 2003, 278:34268-34276.
12. Kubota N., Terauchi Y., Miki H., Tamemoto H., Yamauchi T., Komeda K., et al. PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999, 4:597-609.
13. Rosen E.D., Sarraf P., Troy A.E., Bradwin G., Moore K., Milstone D.S., et al. PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 1999, 4:611-617.
14. Courselaud B., Pigeon C., Inoue Y., Inoue J., Gonzalez F.J., Leroyer P., et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J Biol Chem 2002, 277:41163-41170.
15. Puri P., Mirshahi F., Cheung O., Natarajan R., Maher J.W., Kellum J.M., et al. Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease. Gastroenterology 2008, 134:568-576.
16. Vecchi C., Montosi G., Zhang K., Lamberti I., Duncan S.A., Kaufman R.J., et al. ER stress controls iron metabolism through induction of hepcidin. Science 2009, 325:877-880.
17. Oyadomari S., Harding H.P., Zhang Y., Oyadomari M., Ron D. Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab 2008, 7:520-532.
18. Chen L., Jarujaron S., Wu X., Sun L., Zha W., Liang G., et al. HIV protease inhibitor lopinavir-induced TNF-alpha and IL-6 expression is coupled to the unfolded protein response and ERK signaling pathways in macrophages. Biochem Pharmacol 2009, 78:70-77.
19. Ahmed U., Redgrave T.G., Oates P.S. Effect of dietary fat to produce non-alcoholic fatty liver in the rat. J Gastroenterol Hepatol 2009, 24:1463-1471.
20. Gill G.V., Baylis P.H., Flear C.T., Lawson J.Y. Changes in plasma solutes after food. J R Soc Med 1985, 78:1009-1013.
21. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004, 79:502-509.
22. Turbino-Ribeiro S.M., Silva M.E., Chianca D.A., De Paula H., Cardoso L.M., Colombari E., et al. Iron overload in hypercholesterolemic rats affects iron homeostasis and serum lipids but not blood pressure. J Nutr 2003, 133:15-20.
23. The measurement of total and unsaturated iron-binding capacity in serum. Br J Haematol 1978, 38:281-287.
24. Recommendations for measurement of serum iron in human blood. Br J Haematol 1978, 38:291-294.
25. Revised recommendations for the measurements of the serum iron in human blood. Iron Panel of the International Committee for Standardization in Haematology. Br J Haematol 1990, 75:615-616.
26. Huebers H.A., Eng M.J., Josephson B.M., Ekpoom N., Rettmer R.L., Labbe R.F., et al. Plasma iron and transferrin iron-binding capacity evaluated by colorimetric and immunoprecipitation methods. Clin Chem 1987, 33:273-277.
27. Kaldor I. Studies on intermediary iron metabolism. V. The measurement of non-haemoglobin tissue iron. Aust J Exp Biol Med Sci 1954, 32:795-799.
28. West A.R., Oates P.S. Decreased sucrase and lactase activity in iron deficiency is accompanied by reduced gene expression and upregulation of the transcriptional repressor PDX-1. Am J Physiol Gastrointest Liver Physiol 2005, 289:G1108-G1114.
29. Zheng S., Chen A. Disruption of transforming growth factor-beta signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-gamma in rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 2007, 292:G113-G123.
30. Bridle K., Cheung T.K., Murphy T., Walters M., Anderson G., Crawford D.G., et al. Hepcidin is down-regulated in alcoholic liver injury: implications for the pathogenesis of alcoholic liver disease. Alcohol Clin Exp Res 2006, 30:106-112.
31. Zhang A.S., Xiong S., Tsukamoto H., Enns C.A. Localization of iron metabolism-related mRNAs in rat liver indicate that HFE is expressed predominantly in hepatocytes. Blood 2004, 103:1509-1514.
32. Merle U., Theilig F., Fein E., Gehrke S., Kallinowski B., Riedel H.D., et al. Localization of the iron-regulatory proteins hemojuvelin and transferrin receptor 2 to the basolateral membrane domain of hepatocytes. Histochem Cell Biol 2006.
33. Otogawa K., Ogawa T., Shiga R., Nakatani K., Ikeda K., Nakajima Y., et al. Attenuation of acute and chronic liver injury in rats by iron-deficient diet. Am J Physiol Regul Integr Comp Physiol 2008, 294:R311-R320.
34. Gentle A., Anastasopoulos F., McBrien N. High-resolution semi-quantitative real-time PCR without the use of a standard curve. Biotechniques 2001, 31:504-508.
35. Keenan K.P., Ballam G.C., Dixit R., Soper K.A., Laroque P., Mattson B.A., et al. The effects of diet, overfeeding and moderate dietary restriction on Sprague-Dawley rat survival, disease and toxicology. J Nutr 1997, 127:851S-856S.
36. Walls E.K., Koopmans H.S. Differential effects of intravenous glucose, amino acids, and lipid on daily food intake in rats. Am J Physiol 1992, 262:R225-R234.
37. Oates P.S., Morgan R.G. Changes in pancreatic acinar cell nuclear number and DNA content during aging in the rat. Am J Anat 1986, 177:547-554.
38. Oates P.S., Morgan E.H. Effects of dietary iron loading with carbonyl iron and of iron depletion on intestinal growth, morphology, and expression of transferrin receptor in the rat. Anat Rec 1996, 246:364-371.
39. Andrijauskas A., Ivaskevicius J. New method of tracing blood hemoglobin concentration to hematocrit ratio for monitoring plasma dilution and osmotic origin shifts in blood. Medicina (Kaunas) 2006, 42:181-186.
40. Alpers D.H., Stenson W.F., Taylor B., Bier D.M. Manual of nutritional theraupetics 2008, Lippincott Williams & Wilkins. 5th ed.
41. Abraham R., Ringwood N. Effects of lysosomotropic agents on the hepatic uptake and storage of degraded carrageenan: disparity in response of hepatocytes and Kupffer cells. Exp Mol Pathol 1977, 26:13-27.
42. Fasske E., Morgenroth K. Functional morphology of phagocytosing alveolar macrophages. Long-term electron microscopic and x-ray microanalytical investigations on the rat model. Virchows Arch B Cell Pathol Incl Mol Pathol 1985, 49:195-208.
43. Wood J.K., Milner P.F., Pathak U.N. The metabolism of iron-dextran given as a total-dose infusion to iron deficient Jamaican subjects. Br J Haematol 1968, 14:119-129.
44. Schubert T.E., Bosserhoff A.K., Peyssonaux C., Echtenacher B., Knutson M., Hofstadter F., et al. Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis. Molecular medicine reports 2012, 6:838-842.
45. Graham R.M., Morgan E.H., Baker E. Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin. Eur J Biochem 1998, 253:139-145.
46. Johnson M.B., Chen J., Murchison N., Green F.A., Enns C.A. Transferrin receptor 2: evidence for ligand-induced stabilization and redirection to a recycling pathway. Mol Biol Cell 2007, 18:743-754.
47. Lee A.W., Oates P.S., Trinder D. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells. Hepatology 2003, 38:967-977.
48. Tchernitchko D., Bourgeois M., Martin M.E., Beaumont C. Expression of the two mRNA isoforms of the iron transporter Nramp2/DMTI in mice and function of the iron responsive element. Biochem J 2002, 363:449-455.
49. Gunshin H., Allerson C.R., Polycarpou-Schwarz M., Rofts A., Rogers J.T., Kishi F., et al. Iron-dependent regulation of the divalent metal ion transporter. FEBS Lett 2001, 509:309-316.
50. Gunshin H., Mackenzie B., Berger U.V., Gunshin Y., Romero M.F., Boron W.F., et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388:482-488.
51. Oates P.S., Trinder D., Morgan E.H. Gastrointestinal function, divalent metal transporter-1 expression and intestinal iron absorption. Pflugers Arch 2000, 440:496-502.
52. Drake S.F., Morgan E.H., Herbison C.E., Delima R., Graham R.M., Chua A.C., et al. Iron absorption and hepatic iron uptake are increased in a transferrin receptor 2 (Y245X) mutant mouse model of hemochromatosis type 3. Am J Physiol Gastrointest Liver Physiol 2007, 292:G323-G328.
53. Kawabata H., Fleming R.E., Gui D., Moon S.Y., Saitoh T., O'Kelly J., et al. Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis. Blood 2005, 105:376-381.
54. Lee P.L., Beutler E., Rao S.V., Barton J.C. Genetic abnormalities and juvenile hemochromatosis: mutations of the HJV gene encoding hemojuvelin. Blood 2004, 103:4669-4671.
55. Camargo C.A., Madden J.F., Gao W., Selvan R.S., Clavien P.A. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent. Hepatology 1997, 26:1513-1520.
56. Hong F., Radaeva S., Pan H.N., Tian Z., Veech R., Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004, 40:933-941.
57. Wullaert A., van Loo G., Heyninck K., Beyaert R. Hepatic tumor necrosis factor signaling and nuclear factor-kappaB: effects on liver homeostasis and beyond. Endocr Rev 2007, 28:365-386.
58. Pedersen T.A., Bereshchenko O., Garcia-Silva S., Ermakova O., Kurz E., Mandrup S., et al. Distinct C/EBPalpha motifs regulate lipogenic and gluconeogenic gene expression in vivo. EMBO J 2007, 26:1081-1093.